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Abstract
Background: Both tissue sealants and buttressing have been advocated to reduce alveolar air
leaks from staple lines following Lung Volume Reduction Surgery (LVRS). However, the long term
detrimental effects of buttressing material are increasingly apparent. We performed a pilot
prospective randomised self controlled trial in patients undergoing LVRS comparing BioGlue and
Peri-strips as adjuncts in preventing alveolar air-leaks.
Methods: A pilot prospective self controlled clinical trial was conducted in patients undergoing
LVRS. Each patient was treated with BioGlue on one side and pericardial buttress on the other side
as an adjunct to the staple line. The sides were randomised for adjuncts with each patient acting as
his own control. Duration of air leak, intercostal drainage and time to chest drain removal were
the study end points.
Results: 10 patients undergoing the procedure were recruited between December 2005 and
October 2007. There were 6 men and the mean age was 59.8 ± 4.9 years. There was one mortality
due to multi-organ failure. The BioGlue treated side had a shorter mean duration of air-leak (3.0 ±
4.6 versus 6.5 ± 6.9 days), lesser chest drainage volume (733 ± 404 ml versus 1001 ± 861) and
shorter time to chest drain removal (9.7 ± 10.6 versus 11.5 ± 11.1 days) compared with Peri-strips.
Conclusion: This study demonstrates comparable efficacy of BioGlue and Peri-strips, however
there is a trend favouring the BioGlue treated side in terms of reduction in air-leak, chest drainage
volumes, duration of chest drainage and significant absence of complications. A larger sample size
is needed to validate this result.
Introduction
Lung Volume Reduction Surgery (LVRS) benefits a
selected group of patients with end stage emphysema
[1,2]. A common and troublesome complication of LVRS
is postoperative air leak aggravated by the friable nature of
the underlying lung parenchyma [3,4]. A number of tech-
niques have been utilised to prevent and minimise air
leak, including buttressing materials such as bovine peri-
cardium (Peri-strips) (Synovis Life Technologies Inc, St
Paul MN, USA), poly-tetrafluoroethylene (PTFE), Teflon,
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number of surgical sealants are in use to achieve pneu-
mostasis after pulmonary surgery [3,7-10].
BioGlue surgical sealant (CryoLife Inc. Kennesaw, U.S.A)
is a topically applied mixture of bovine serum albumin
and glutaraldehyde. It is approved for use as an adjunct to
standard methods of haemostasis and for use in a wide
range of soft tissue repairs. BioGlue has also been shown
to reduce air leaks, length of chest drains and hospital stay
in thoracic surgical practice [9]. However, at present there
are no published reports regarding the utility or efficacy of
BioGlue in LVRS patients.
The principal aim of our pilot randomised self controlled
trial was to compare the use of BioGlue and buttressed
pericardial strips in controlling postoperative air leak fol-
lowing LVRS. This was assessed by clinically relevant out-
come measures of duration of air leak, drainage volume
and time to drain removal. We report the results of our
pilot phase in this paper.
Materials and methods
Patient Selection
A prospective, randomised self controlled trial with the
approval of the East Birmingham Research Ethics Com-
mittee was performed at Birmingham Heartlands Hospi-
tal between December 2005 and October 2007. We used
the CONSORT checklist for design and conduct of this
study. As there are no comparative trials comparing these
interventions we designed the study in two phases a pilot
phase of ten patients to review the results and to calculate
a sample size for the trial. An informed patient consent
was obtained before each operation. Patients undergoing
bilateral LVRS through a median sternotomy incision
were included in the study. Patients with asymmetrical
disease and known allergies to bovine pericardium and
albumin were excluded. All patients had routine work-up
for LVRS according to our unit protocol, comprising full
lung function tests, high resolution CT scanning (HRCT),
quantitative ventilation-perfusion scanning, echocardiog-
raphy in patients with previous cardiac history, smoking
cessation and pulmonary rehabilitation.
Randomisation
Randomisation was undertaken with sequential closed
envelopes containing the treatment strategies assigned to
each side. In each case, the operating surgeon opened the
envelope on the day of surgery to assign the treatment
strategy to each side (Figure 1).
Surgery
All patients had a peri-operative epidural catheter sited for
pain relief. The surgery was performed under general
anaesthesia with a double lumen endotracheal tube and
sequential single lung ventilation. The surgical access was
gained through median sternotomy. The target areas were
identified based on preoperative CT scan, ventilation per-
fusion scan as well as by direct per-operative observation
and palpation of lung parenchyma. The pleural cavity was
entered after instituting single lung ventilation to the con-
tra lateral side. After few minutes of suspending ventila-
tion, the relatively better part of the lung parenchyma
tends to collapse thus demarcating the worst areas for
excision. The line of excision began at the medial aspect,
near the horizontal fissure for the right upper lobe and
near the base of the lingula for the left upper lobe. With
successive applications of the GIA 80 stapler (Auto Suture,
Tyco Healthcare Norwalk CN, USA), the line of excision
was carried up toward the apex, angled postero-laterally,
and then angled downward on the postero-lateral portion
of the upper lobe ending up near the top of the oblique
fissure. Thus an inverted 'U' shaped continuous staple line
was formed. The resection was limited to the level of the
azygos vein on the right and to the aortic arch on the left.
Intervention
BioGlue was applied on the stapled margins using a
spreader tip. The unique double-helix delivery system
attached to a syringe enables swift mixing of two compo-
nents of the product. The lung was gently re-inflated after
two minutes. In the other group Peri-strips were applied
onto the jaws of the GIA stapler before applying them on
the lung parenchyma.
Study ProtocolFigure 1
Study Protocol.
Acceptance for LVRS
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After ensuring pneumostasis, 28F apical and basal drains
were placed in the pleural space and brought out through
separate stab incisions. The pleural openings on either
side were closed with a continuous run of 4/0 prolene
suture (Ethicon USA) to prevent crossover air leak. Once
the pleurae were isolated the air-leak check was repeated
to rule out crossover air leaks.
The anaesthetist carefully avoided over-inflation of the
operated lung letting the lung inflate gently accepting a
period of relative hypercarbia. At the end of the proce-
dure, the sternum was closed with sternal wires and the
pre-sternal fascia and skin were closed in layers. The
patients were all extubated at the end of the operation and
nursed in the thoracic high dependency unit.
Postoperative Care
The chest drains were connected to underwater seal drain-
age systems individually and left without suction. The
drains were connected to flutter valve bags (Portex Ltd,
Hythe UK) once the drainage was less than 100 mls/day
to enable mobilisation. The chest drains were removed
following cessation of the air leak, confirmation of full
expansion of the lung and drainage less than 100 ml in 24
hours. This was achieved in majority of patients. How-
ever, if there was persistent air leak or the lung failed to
expand after seven days, the patient was discharged home
with drain connected to a flutter valve bag, which was
removed subsequently. The patients were routinely fol-
lowed up to 6 weeks after surgery.
In this study, the postoperative air leak was defined as the
presence of air bubbles in the chest drains during the
course of normal or forced expiration (coughing). The
investigators performed daily objective assessments that
were concurrently verified by independent blinded senior
nursing staff.
Statistical Analysis
The results are expressed as mean ± standard deviation.
The sides randomised to each arm were grouped accord-
ing to treatment allocation, and compared with t tests for
normally distributed measures and Mann-Whitney tests
for non-normally distributed measures.
Results
Demographics
A total of 10 patients were recruited and consented over a
period of 24 months into this study. There were 6 men
with a mean age of 59.8 ± 4.9 years. All patients had dis-
continued smoking prior to surgery. The median Karnof-
sky performance scale of this group was 70%. Co-
morbidities included hypertension (n: 1), diabetes melli-
tus (n: 1) and aortic regurgitation (n: 1). There was no sig-
nificant difference in the distribution of emphysema
between the two treatment sides as assessed by independ-
ent review of HRCT and quantitative ventilation perfusion
imaging. A summary of pre-operative investigations is
presented in Table 1.
Cessation of Air-leak
There was shorter mean duration of air leak, less drainage
and chest drains were removed earlier in the BioGlue
group but these do not reach statistical significance due to
small numbers (Figure 2, Table 2). There was a tendency
for earlier cessation or comparable duration of air leak in
the BioGlue arm on direct comparison between the two
treatment sides in all but one patient. Two patients did
not have any post operative air leak. BioGlue treated sides
had comparable duration of air leak with Peri-strips
treated sides. In three patients the BioGlue treated side
had significantly shorter air-leak duration and one patient
had a longer air-leak in the BioGlue treated side (Figure
3).
When comparing the number of subjects with air-leak on
each of the post operative days there was only one patient
in the BioGlue treated side who had prolonged air leak
(duration more than 7 days) compared with four in the
Peri-strips treated side (Figure 4).
Complications
There was single mortality on the 38th post operative day,
due to postoperative respiratory failure leading to multi-
organ failure.
No adjunct related complications were encountered in the
BioGlue arm. In Peri-strips side, one patient had air leak
at the end of the procedure from the junction of two staple
lines and required extra pneumostasis with insertion of
Table 1: Demographics and Investigations
Variable
Age (Mean ± SD) 59.8 ± 4.9 years
Sex (M:F) 6:4
Predicted FEV1 % Mean (Range) 22 (19–47)
Residual Volume % Mean (Range) 225 (172–260)
KCO % Mean (Range) 36 (15–58)
Lung Volume Resected in cm3 Mean (Range) Bioglue:Peri-strips 194 (47–504):174 (46–365)Page 3 of 6
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failure, it may still be considered as adjunct failure.
BioGlue application on the staple confluence may have
sealed the leak where as with the Peri-strips it is incorpo-
rated into the overlapped stapling lines therefore neces-
sacitating extra sutures. One patient had prolonged air
leak on the Peri-strips treated side and was discharged
home on a flutter valve bag. Another patient coughed up
part of the Peri-strips three months after the surgical pro-
cedure.
Discussion
Lung Volume Reduction Surgery for emphysema has
evolved over the last two decades since the original
description by Brantigan [11]. Cooper and colleagues
popularised the use of stapled excision of the emphyse-
matous lung with good outcomes [1]. This was followed
by a number of groups pursuing varied selection criteria
and techniques with mixed results [4,12-14]. However,
the selection criteria and benefits of LVRS in end stage
emphysema has been established in the National Emphy-
sema Treatment Trial [2] with durable long term results in
select group of patients [15].
One of the major complications of stapled LVRS is pro-
longed air leak which occurs in 50–90% of the patients
[3]. A number of adjuncts to prevent air leak have been
advocated which include bovine pericardium, Gore-Tex
or autologous pleura [3,6]. The buttressing of the staple
line has been shown to reduce the duration of air leak and
time to chest drain removal [6]. In our centre, the stand-
ard approach to Lung Volume Reduction Surgery is
through a median sternotomy incision and bilateral sta-
pled excision with Peri-strips buttressing. We refrained
from performing thoracoscopic LVRS because of the lack
of endoscopic buttressing materials at the time of design-
ing this study.
Though the buttressing adjuncts result in better pneumos-
tasis, there are many documented cases of migration of
the buttressing pericardium [5,16,17] or associated sta-
ples [18,19] sometimes resulting in harm to the patient.
Following LVRS, we believe that the staple line causes a
shearing force on the lung parenchyma which results in
Table 2: Comparative outcome between the groups
BioGlue Peri-strips P
Air leak (days) 3.0 ± 4.6 6.50 ± 6.88 0.27
Drainage Volume(ml) 733 ± 404 1001 ± 861 0.65
ICD duration (days) 9.7 ± 10.6 11.5 ± 11.1 0.73
Comparison of duration of air leak and chest drainage in the two groupsFigure 2
Comparison of duration of air leak and chest drainage in the two groups. (mean ± standard deviation).
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Comparative results of BioGlue and Peri-strips in each patientFigure 3
Comparative results of BioGlue and Peri-strips in each patient. The graph represents the number of days with air leak 
in the BioGlue arm on the left side and Peri-strips arm on the right side and links each patient with a bar. Two patients with 
identical values are superimposed on one another.
Early cessation of air leak in the BioGlue arm on a day to day basisFigure 4
Early cessation of air leak in the BioGlue arm on a day to day basis.
	


Journal of Cardiothoracic Surgery 2009, 4:37 http://www.cardiothoracicsurgery.org/content/4/1/37damage to the lung contributing to the air leak. Alterna-
tive adjuncts used for pneumostasis are tissue sealants and
glues which are applied on the staple line and adjacent
normal lung to prevent the shearing tears on the lung
[20]. Although BioGlue has been used in certain centres in
the NETT trial it was used as an additional adjunct to but-
tressed staple line [3]. However its role as a sole pneumo-
static agent has not been tested in the LVRS setting. This
randomised controlled trial compared BioGlue and Peri-
strips as an adjunct to the stapled line in LVRS patients. In
order to minimise individual patient bias we elected to
allow patients to act as their own control.
Conclusion
This pilot randomised self controlled trial demonstrates
the comparable efficacy and safety of BioGlue in LVRS
compared to Peri-strips reinforcement of staple lines.
There is a trend favouring the BioGlue treated side in
terms of reduction in air leak, chest drainage volumes and
duration of chest drainage and significant absence of com-
plications in the BioGlue treated sides. We need a large
sample size to validate these results.
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